Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Toxicokinetics: Overview

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...

Toxic Reactions: Overview

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

Drug Toxicity: Overview

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Clinical features and fistula acoustic characteristics in maintenance hemodialysis patients with versus without diabetes mellitus].

Zhonghua yi xue za zhi·2026

Same author

X-linked hypophosphatemic rickets: a rare case report.

Acta orthopaedica Belgica·2026

Same author

[Kidney transplantation in low-age, low-weight children: A report of two cases].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2025

Same author

[The clinical research of IFNGR1 proximal promoter polymorphism in susceptibility and prognosis of breast cancer].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025

Same author

The lipidomic profiling of ovine sperm reveals metabolic alterations and key biomarkers after cryopreservation.

Cryo letters·2025

Same author

Normal tissue complication probability model predicting taste impairment in head and neck cancer patients: Evaluating the taste bud bearing tongue mucosa as a predictor.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025

Search research articles

Related Experiment Video

Updated: May 13, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

The liver toxicity knowledge base: a systems approach to a complex end point.

M Chen¹, J Zhang, Y Wang

¹Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, Arkansas, USA.

Clinical Pharmacology and Therapeutics

|March 15, 2013

Summary

Drug-induced liver injury (DILI) is a significant public health concern. The Liver Toxicity Knowledge Base (LTKB) enhances DILI understanding and prediction using integrated data analysis and predictive models for research and regulation.

More Related Videos

An All-Human Hepatic Culture System for Drug Development Applications

An All-Human Hepatic Culture System for Drug Development Applications

Published on: October 20, 2023

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Related Experiment Videos

Last Updated: May 13, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

An All-Human Hepatic Culture System for Drug Development Applications

An All-Human Hepatic Culture System for Drug Development Applications

Published on: October 20, 2023

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Area of Science:

Pharmacology
Toxicology
Biomedical Informatics

Background:

Drug-induced liver injury (DILI) poses significant challenges in public health, drug development, and regulatory processes.
Understanding the mechanisms and predicting DILI are critical for ensuring drug safety.

Purpose of the Study:

To develop a centralized resource, the Liver Toxicity Knowledge Base (LTKB), to enhance the understanding of DILI.
To improve the prediction of DILI through integrated analysis of diverse drug-elicited data.

Main Methods:

Development of the Liver Toxicity Knowledge Base (LTKB) as a centralized data repository.
Integrated analysis of various sources of drug-elicited data.
Creation of predictive models for DILI.

Main Results:

Establishment of a comprehensive and centralized resource for DILI-related data.
Development of predictive models to aid in DILI assessment.
Facilitation of integrated data analysis for enhanced DILI understanding.

Conclusions:

The LTKB provides a valuable resource for DILI research.
The developed predictive models can support drug development and regulatory decision-making.
Integrated analysis of drug-elicited data is crucial for improving DILI prediction and management.